English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Background   Rheumatoid arthritis (RA) is a chronic inflammatory joint disease, which can cause cartilage and bone damages as well as pain and disability. In order to prevent disease progression, reduce pain, and major symptoms of RA, one good strategy consists in targeting proinflammatory cytokines that have the key role in the vicious circle of synovial inflammation and pain. The micro-immunotherapy medicine (MIM) 2LARTH® targets cytokines involved in inflammation.Aim   The aim of the study is to evaluate the effect of the MIM compared to vehicle in an  in vivo  model of RA, induced in mice after immunization with articular bovine type II collagen.Methods   Vehicle and MIM were dissolved in pure water (1 capsule in 100 ml) and 100  µ l was given by gavage daily for 14 days. To evaluate the severity of arthritis, wrist and ankle thickness was determined, paw edema was measured, and a clinical score from 0 to 4 was established. Furthermore, histological analysis was performed. To evaluate systemic inflammation, circulating levels of IL-1 β  and TNF- α  were measured by ELISA.Results   Ankle thickness was found to be significantly reduced in MIM-treated mice compared to vehicle-treated mice ( P  < 0.05) and compared to untreated me ( P  < 0.05) and compared to untreated me ( P  < 0.05) and compared to untreated me ( β  and TNF- α  were measured by ELISA.  P  < 0.05) and compared to untreated me (    Conclusion   The results indicate that the tested medicine reduces inflammation, histological, and clinical signs of RA in a CIA model.

The Micro-Immunotherapy Medicine 2LARTH® Reduces Inflammation and Symptoms of Rheumatoid Arthritis In Vivo